Matti Vauhkonen
Overview
Explore the profile of Matti Vauhkonen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molander P, Af Bjorkesten C, Mustonen H, Haapamaki J, Vauhkonen M, Kolho K, et al.
Inflamm Bowel Dis
. 2012 Jan;
18(11):2011-7.
PMID: 22223566
Background: Fecal calprotectin (FC) concentration is a useful surrogate marker for mucosal healing (MH) during tumor necrosis factor alpha (TNFα)-blocking therapy for inflammatory bowel disease (IBD). Our aim was to...
2.
Vauhkonen M, Vauhkonen H, Sipponen P
Scand J Gastroenterol
. 2008 Dec;
43(8):915-21.
PMID: 19086163
Objective: The homeobox gene CDX2 is implicated in the appearance of intestinal metaplasia in Helicobacter pylori gastritis. The aim of this study was to investigate whether CDX2 expression in gastric...
3.
Vauhkonen M, Raade M, Lehto V, Farkkila M
Duodecim
. 2007 Nov;
123(14):1747-55.
PMID: 18027828
No abstract available.
4.
Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S
Cancer Genet Cytogenet
. 2006 Oct;
170(2):133-9.
PMID: 17011984
Gastric cancer (GCA) displays a variety of genomic aberrations, including DNA copy number alterations, microsatellite instability (MSI), and loss of heterozygosity (LOH). The main aim of the present work was...
5.
Vauhkonen M, Vauhkonen H, Sipponen P
Best Pract Res Clin Gastroenterol
. 2006 Sep;
20(4):651-74.
PMID: 16997151
Several attempts to classify gastric cancer (GCA) have been made over the past decades. Most successful, and widely used, is the classification by Laurén, which distinguishes, by microscopical morphology alone,...
6.
Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S
Cancer Genet Cytogenet
. 2006 Jun;
167(2):150-4.
PMID: 16737915
Genomic instability can be divided into 2 categories: chromosomal instability (CIN) and microsatellite instability (MSI). CIN has been linked to aneuploidy and chromosomal aberrations, and high-level loss of heterozygosity (LOH-H)...
7.
Vauhkonen M, Vauhkonen H, Sajantila A, Sipponen P
Gastric Cancer
. 2005 Dec;
8(4):238-44.
PMID: 16328598
Background: Microsatellite instability (MSI) and loss of heterozygosity (LOH) are lesions in the genome found with different frequencies in gastric carcinomas (GCAs). Despite a great body of studies, no systematic...
8.
Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen M
World J Gastroenterol
. 2005 Nov;
11(38):5988-92.
PMID: 16273611
Aim: To examine whether the fasting levels of serum gastrin-17 (G-17) are lower in Barrett's esophagus (BE) patients than in non-Barrett controls. Methods: Nineteen patients with BE (presenting with a...
9.
Vauhkonen H, Hedman M, Vauhkonen M, Sipponen P, Sajantila A
J Forensic Sci
. 2004 Mar;
49(2):222-6.
PMID: 15027535
DNA profiling of a cancer tissue can be problematic because of genomic instability. Here we have analyzed gastrointestinal cancer specimens from 46 males, of which seven (15%) showed aberrations in...